4d Molecular Therapeutics In shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $9.9M | 487k | 20.26 |
| 2023-09-30 | $198k | 16k | 12.73 |
| 2023-06-30 | $12M | 676k | 18.07 |
| 2023-03-31 | $1.4M | 80k | 17.19 |
| 2022-12-31 | $1.7M | 75k | 22.21 |
| 2022-09-30 | $589k | 73k | 8.03 |
| 2022-06-30 | $93k | 13k | 7.00 |
| 2022-03-31 | $249k | 16k | 16.03 |
| 2021-12-31 | $388k | 17k | 22.44 |
| 2021-09-30 | $432k | 17k | 25.64 |
| 2021-06-30 | $273k | 11k | 25.64 |
| 2021-03-31 | $436k | 9.7k | 44.87 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft